发明名称 |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
摘要 |
The present invention relates to compounds of formula I: or pharmaceutically acceptable salts thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are useful as antiviral agents. The invention further relates to pharmaceutically acceptable compositions comprising said compounds either for ex vivo use or for administration to a patient suffering from HCV infection and to processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a pharmaceutical composition comprising a compound of this invention.
|
申请公布号 |
US7906550(B2) |
申请公布日期 |
2011.03.15 |
申请号 |
US20080026705 |
申请日期 |
2008.02.06 |
申请人 |
VERTEX PHARMACEUTICALS INCORPORATED |
发明人 |
COTTRELL KEVIN M.;MAXWELL JOHN;PERNI ROBERT B.;PITLIK JANOS |
分类号 |
A61K31/4025;A61K31/40;A61K38/04;C07D207/30;C07D403/12;C07K5/04;C07K5/10 |
主分类号 |
A61K31/4025 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|